Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000914208-16-000739
Filing Date
2016-02-10
Accepted
2016-02-10 15:50:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G 16632
2 JOINT FILING AGREEMENT Rule13D_JointFilingAgreement.htm EX-99 5350
  Complete submission text file 0000914208-16-000739.txt   24021
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39444 | Film No.: 161405611
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309
Business Address 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309 404-892-0896
Invesco Ltd. (Filed by) CIK: 0000914208 (see all company filings)

EIN.: 980557567 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice